Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Immune Semaphorins in NAFLD

NCT04573543 is registered in ClinicalTrials.gov with University Hospital for Infectious Diseases, Croatia as lead sponsor.

NCT NCT04573543
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04573543 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Immune Semaphorins in NAFLD
Lead sponsor
University Hospital for Infectious Diseases, Croatia
Phase
Observational
Overall status
Completed
Start date
September 1, 2020
Completion date
March 1, 2022
Enrollment
160 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biomarkers, immune response, liver fibrosis, non alcoholic steatohepatitis, non-alcoholic fatty liver disease